Your Position: King Quenson Group > News > Industry News
Compound patent of Chlorantraniliprole will be expired in 2022
2022/4/20 14:27:00

Compound patent of Chlorantraniliprole will be expired in 2022


Chlorantraniliprole is the top-selling product of DuPont's and the world's top insecticide. It has successfully replaced Thiamethoxam in its leading position. Since its launch in 2008, the growth of Chlorantraniliprole's sales led significant growth to DuPont's crop protection business.


The global sales of Chlorantraniliprole

Chlorantraniliprole reached the peak of the pesticide market through 6 years with compound annual growth rate of 46.4% from 2008 to 2014. From 2015-2017, the sales of Chlorantraniliprole have slowed down. The compound annual growth rate of 26% from 2008 to 2017. Sales of Chlorantraniliprole reached to 1592 million in 2018.


The U.S. Environmental Protection Agency (EPA) classifies Chlorantraniliprole as a “Reduced Risk” pesticide. This means that Chlorantraniliprole poses a lower risk to human health and the environment than other pesticides allowed for the same uses.


Chlorantraniliprole has been sold in more than 100 countries in the world, covering almost all major markets. Soybeans, fruits and vegetables are its main crop markets. At the same time, the product has also gained a large market share in cotton and rice.


Because of the leading position of Chlorantraniliprole in pesticides, its patent situation attracts much attention. Compound patent of Chlorantraniliprole EP1416797B1 in EU and CN100391338C in China will be both expired on August 12, 2022, EP1416797B1 in US will be expired on August 13, 2022.


Chlorantraniliprole still has the beautiful insights after its patent expiry date, and we also hope Chlorantraniliprole can be service for the agriculture as long time as possible.


Overview of Chlorantraniliprole.

Chlorantraniliprole is a new insecticide belonging to the anthranilic diamide class of chemistry and is intended for the control of Lepidopteran, Coleopteran, and some Dipteran pests in commercial agriculture on both perennial and annual crops.



Chlorantraniliprole demonstrated excellent performance on codling moth and other chewing pests, stability of performance across the different conditions and minimal impact on pollinators, beneficial insects and predatory mites.


Function and Feature:

Effective control in 60 seconds

Insects stop feeding in 7 minutes

24 hours insects dead and black

Excellent systemic action and penetrability

Effective on eggs and each stage of larva

Long lasting protection for more than 25 days



Chlorantraniliprole has very low toxicity for mammals (both acute and chronic), high intrinsic activity on target pests, strong ovilarvicidal and larvicidal properties, long lasting crop protection and no cross-resistance to any existing insecticide.

Oral: Acute oral LD50 for rats > 5000 mg/kg

Dermal: Acute percutaneous LD50 for rats > 5000 mg/kg

Inhalation: LC50 for rats > 5.1 mg/L

Skin irritation: Non-irritating to skin. (rabbits)                    

Eye irritation: Non-irritating to eyes (rabbits)

Sensitization: Not a skin sensitizer (Guinea pigs)

Carcinogenicity: No evidence of carcinogenicity.

Neurotoxicity: No evidence of neurotoxicity was observed

Safety to workers: No reports of adverse health effects in manufacturing personnel or agricultural workers have been received.


Registration support:

Chlorantraniliprole SC and GR formulation is available under the authorization of FMC.


Since 2003, King Quenson has been thriving to introduce the latest technologies to agricultural industries and farmers to achieve mutual development and prosperity. With years of dedication and rich experience, King Quenson devotes more than 18 years to crop protection and offers solutions.


If you have a need, you can contact us at any time:


Tel: 86-755-86612760, 86-755-86612793

Prev: From Jan. To Mar. 2022, China Exported 4.16 Million Tons of Fertilizers and Imported 2.44 Million Tons

Next: EU Will Loss Three Key Insecticides—Spirotetramat, Spinetoram and Flubendiamide